CAR T Cells Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Advanced Therapy Safety Management: Proactive Strategies for Real-World Risk Detection

September 25, 2025

High-Titer Lentivirus Solutions in 5 Days: Break Production Barriers for CGT

September 04, 2025

Autolus Wins FDA Approval for B-ALL CAR T-Cell Therapy Aucatzyl, May Have Edge Over Competitors

November 12, 2024

Life Science Podcast

A Unique Approach to in vivo CAR T Therapy and New Advancements in the Field

October 9, 2024

Expanding CAR T Beyond Oncology: Medical, Operational & Practical Considerations

October 29, 2024

Exploring Applications of CAR-T Therapy Outside Oncology: Strategies for Applying Lessons Learned

J&J’s Carvykti and BMS’ Abecma Win FDA Approvals for Earlier Use in Multiple Myeloma

FDA Advisory Committee Backs Carvykti and Abecma for Earlier Myeloma Treatment

FDA Raises Concerns Over Early Trial Deaths for CAR T-Cell Therapies Carvykti and Abecma

The Age of Cell and Gene Therapies is Upon Us! What Does it Mean for Bioanalysis?

Adoptive Cell Therapeutics: Logistics & Lab Testing

Rare Fatal Relapse After CAR-T Cell Therapy Highlights Need for Stringent Manufacturing Specifications for Kymriah

October 3, 2018

CAR-T Cell Therapy Shows Promise as Leukemia Treatment in Early Stage Clinical Trial